Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Future Science OA Pub Date : 2023-01-01 DOI:10.2144/fsoa-2022-0046
Wafa Dahmani, Sahar Nasr, Kais Maalel, Yasser Becheikh, Ahmed Tibaoui, Zainab Lajmi, Sihem Hmissa, Hanene Jaziri, Nour Elleuch, Aida Ben Slama, Wafa Ben Ameur, Mahdi Ksiaa, Ali Jmaa
{"title":"Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.","authors":"Wafa Dahmani,&nbsp;Sahar Nasr,&nbsp;Kais Maalel,&nbsp;Yasser Becheikh,&nbsp;Ahmed Tibaoui,&nbsp;Zainab Lajmi,&nbsp;Sihem Hmissa,&nbsp;Hanene Jaziri,&nbsp;Nour Elleuch,&nbsp;Aida Ben Slama,&nbsp;Wafa Ben Ameur,&nbsp;Mahdi Ksiaa,&nbsp;Ali Jmaa","doi":"10.2144/fsoa-2022-0046","DOIUrl":null,"url":null,"abstract":"<p><p>Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 1","pages":"FSO836"},"PeriodicalIF":2.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051143/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2022-0046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复发性原发性肝脂肪瘤手术切除加局部局部治疗。
血管活性肠肽(VIP)分泌瘤(VIPomas)是一种主要起源于胰岛细胞的隐匿性功能性神经内分泌肿瘤。肝定位被认为是极其罕见的,只有少数病例报道在文献中。这种肿瘤的诊断和治疗管理仍然没有明确的法规,因此对临床医生来说是一个真正的挑战。在此,我们报告一个独特的情况下,原发性肝VIPoma复发的女性患者22年后治愈性切除。患者接受了两次经动脉化疗栓塞。自第一次治疗后的第一天起,症状完全改善。这个病例强调了对肝腺瘤患者的长期随访是必要的,因为在根治性手术治疗几年后可能会复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
期刊最新文献
Endoscope disinfectant-induced colonic pseudolipomatosis: case series of a rare condition. A comprehensive approach for detection of biotin deficiency from dried blood spot samples using liquid chromatography-mass spectrometry. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis. Formulation and characterization of antibiotic drug loaded aquasome for the topical application. Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1